Just re watched this video, couple of interesting points I noted:
- R & D tax incentive expected “soon” (previously come in around the 2-2.5million mark)
- Expecting to reach their goal of patient numbers in the “near future”
Looks to be setting up nicely for a run.
I’m also thinking the cash situation should be fine until after the ibxoa conversion.
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers, page-7
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
